Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date Enzalutamide in the Treatment of Prostate CancerRelease Date:Partner: National Comprehensive Cancer Network, AstellasResearch Oncology USA Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic DermatitisRelease Date:Education Inflammation & Immunology Japan Addressing Primary Immunodeficiencies within Minority/Underserved PopulationsRelease Date:Education Hospital USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.Release Date:Research Rare Disease USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant ProgramRelease Date:Quality Improvement Rare Disease USA Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)Release Date:Education Hospital All Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic DiseasesRelease Date:Partner: The Japan College of RheumatologyQuality Improvement Inflammation & Immunology Japan A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative DiseaseQuality Improvement Internal Medicine USA Establishment of Support System for Healthy Life Extension of Patients with CV diseaseRelease Date:Quality Improvement Internal Medicine Japan Racial and Ethnic Disparities in the Menopause ExperienceRelease Date:Education Internal Medicine USA Immunotherapy in Urothelial CarcinomaRelease Date:Partner: Merck KGaA Darmstadt, Germany and EMD SeronoEducation Oncology All Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASHRelease Date:Education Internal Medicine All NSCLC Biomarker TestingRelease Date:Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom Development of Talazoparib for Prostate CancerRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA Approaches to Smoking Cessation CounselingRelease Date:Education Internal Medicine Australia, India, Japan, New Zealand, Singapore, Taiwan Burden of Community Acquired PneumoniaRelease Date:Research Vaccines USA Closing Knowledge Gaps in Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology USA Progress in Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Efforts to Promote Team-based Care and Regional Medical Collaboration for Cancer PatientsRelease Date:Partner: Japan Society of Clinical OncologyQuality Improvement Oncology Japan ISID-Pfizer 2021 Grant ChallengeRelease Date:Partner: The International Society for Infectious Diseases (ISID)Quality Improvement Hospital All Hemophilia: Improve Knowledge Level of Gene TherapyRelease Date:Education Rare Disease Japan Data generation on the treatment of Metastatic Breast Cancer with CDK 4/6 inhibitorsRelease Date:Research Oncology Portugal China Medical Education in Breast Cancer Diagnosis and TreatmentRelease Date:Education Oncology China COVID-19 Epidemiology ResearchRelease Date:Research Vaccines Algeria, Egypt, Indonesia, Lebanon, Philippines, Thailand, Tunisia, Vietnam Understanding Healthcare disparities in IBD Patients in Underserved CommunitiesRelease Date:Quality Improvement Inflammation & Immunology Canada, USA Latin America Needs Assessment of Mental HealthRelease Date:Education Internal Medicine Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Mayo ClinicReview Process: Expert Review PanelQuality Improvement Rare Disease All Identifying and Diagnosing Juvenile Idiopathic Arthritis (JIA)Release Date:Education Inflammation & Immunology USA Antibiotic Stewardship in PediatricsRelease Date:Quality Improvement Hospital All China Educational Needs Assessment in Atopic DermatitisRelease Date:Education Inflammation & Immunology China China Medical Education in Atopic Dermatitis Awareness and TreatmentRelease Date:Education Inflammation & Immunology China Educational Activities to Improve Vaccination Rate beyond Clinical DepartmentsRelease Date:Education Vaccines Japan Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Emerging Markets (Asia, Latin America, Africa, and Middle East)Release Date:Education Rare Disease All Improving the Knowledge Gap on Vaccine Safety AssessmentRelease Date:Education Vaccines Japan Promotion of the Appropriate Diagnosis and Treatment of Pediatric Neurogenic BladderRelease Date:Education Internal Medicine Japan Improve the Treatment Environment for Cancer Pain PatientsRelease Date:Education Internal Medicine Japan Promoting Pain Treatment in Osteoarthritis CareRelease Date:Education Internal Medicine Japan Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)Release Date:Quality Improvement Inflammation & Immunology All Developing Clinical Research and Publication Skills（Asia, AfME, Latin America and China）Release Date:Partner: British Medical Journal (BMJ)Education Internal Medicine All A Phased Approach to Understanding and Addressing Healthcare Disparities for People of ColorRelease Date:Partner: Conquer Cancer, The ASCO FoundationResearch Oncology USA PCF-Pfizer-Myovant Relugolix Challenge AwardsRelease Date:Partner: The Prostate Cancer Foundation and Myovant Sciences GmbHResearch Oncology USA BRAF-mutation Biomarker Testing in Colorectal Cancer and MelanomaRelease Date:Quality Improvement Oncology Canada Pfizer Innovation Challenge: Patient Preference Database BlueprintRelease Date:Research Support for the Professions All Management of Uterine Fibroids and EndometriosisEducation Internal Medicine USA COVID-19 Impact and SARS-CoV-2 Viral LifecycleRelease Date:Education Hospital USA Addressing Knowledge Gaps on Biosimilar Use in Inflammatory ConditionsRelease Date:Education Inflammation & Immunology USA Dermatology Research Fellowship in Skin of ColorFellowship Inflammation & Immunology USA NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)Release Date:Quality Improvement Oncology All